Cargando…
Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac
PURPOSE: For patients treated with partial breast irradiation (PBI), potential long-term treatment-related toxicities are important. The 1.5 T magnetic resonance guided linear accelerator (MRL) offers excellent tumor bed visualization and a daily treatment plan adaption possibility, but MRL-specific...
Autores principales: | De-Colle, C., Dohm, O., Mönnich, D., Nachbar, M., Weidner, N., Heinrich, V., Boeke, S., Gani, C., Zips, D., Thorwarth, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217770/ https://www.ncbi.nlm.nih.gov/pubmed/35412045 http://dx.doi.org/10.1007/s00066-022-01930-5 |
Ejemplares similares
-
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator
por: De-Colle, C., et al.
Publicado: (2021) -
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation
por: Bonomo, Pierluigi, et al.
Publicado: (2020) -
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance
por: Gani, Cihan, et al.
Publicado: (2020) -
Automatic 3D Monte-Carlo-based secondary dose calculation for online verification of 1.5 T magnetic resonance imaging guided radiotherapy()
por: Nachbar, Marcel, et al.
Publicado: (2021) -
Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation
por: Thorwarth, Daniela, et al.
Publicado: (2020)